Vectorite Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	13.91	30.6	25.32	27.87	39.2	28.76
Short-Term Investments	162.8	-	-	179.7	154.5	60.8
Trading Asset Securities	-	154.3	178.36	5.94	45.68	-
Cash & Short-Term Investments	176.7	184.9	203.67	213.52	239.38	89.56
Cash Growth	-8.58%	-9.21%	-4.61%	-10.80%	167.28%	-22.34%
Accounts Receivable	8.61	6.11	5.64	5.59	1.11	2.3
Other Receivables	0.22	0.46	0.06	0.16	0.76	0.37
Receivables	8.83	6.56	5.69	5.75	1.87	2.67
Inventory	17.19	14.79	10.04	4.83	7.24	5.32
Prepaid Expenses	1.96	2.22	3.73	7.97	1.84	1.42
Total Current Assets	204.68	208.47	223.13	232.06	250.32	98.98
Property, Plant & Equipment	173.12	172.4	178.33	182.73	190.7	197.83
Long-Term Investments	25.7	15.5	23.33	23.4	24.24	37.31
Other Intangible Assets	5.79	6.04	21.81	22.54	22.54	30.12
Other Long-Term Assets	7.8	10.36	5.51	5.1	4.85	4.85
Total Assets	417.08	412.78	452.1	465.82	492.65	369.09
Accounts Payable	1.46	1.14	1.2	3.18	2.72	1.66
Accrued Expenses	5.42	6.05	7.02	4.85	6.39	8.15
Current Portion of Leases	0.17	-	-	-	-	-
Current Unearned Revenue	5.81	5.31	3.13	5.25	5.89	3.03
Other Current Liabilities	2.34	2.33	1.38	2.27	1.61	1.87
Total Current Liabilities	15.21	14.83	12.73	15.55	16.61	14.69
Long-Term Leases	0.3	-	-	-	-	-
Long-Term Unearned Revenue	8.1	8.16	8.51	8.93	9.09	9.3
Other Long-Term Liabilities	0.01	0.21	0.01	0.01	0.01	0.01
Total Liabilities	23.62	23.2	21.25	24.49	25.71	24
Common Stock	437.71	437.71	437.71	721.4	721.4	571.4
Additional Paid-In Capital	11.67	11.67	11.67	101.14	101.14	101.68
Retained Earnings	-42.83	-46.65	-6.6	-373.17	-346.75	-326.13
Comprehensive Income & Other	-13.46	-13.56	-12.34	-8.48	-9.29	-2.34
Total Common Equity	393.09	389.16	430.44	440.9	466.51	344.61
Minority Interest	0.37	0.42	0.41	0.44	0.43	0.47
Shareholders' Equity	393.46	389.58	430.85	441.34	466.94	345.08
Total Liabilities & Equity	417.08	412.78	452.1	465.82	492.65	369.09
Total Debt	0.47	-	-	-	-	-
Net Cash (Debt)	176.23	184.9	203.67	213.52	239.38	89.56
Net Cash Growth	-8.82%	-9.21%	-4.61%	-10.80%	167.28%	-5.78%
Net Cash Per Share	4.03	4.23	4.65	4.88	5.57	3.06
Filing Date Shares Outstanding	43.77	43.77	43.77	43.77	43.77	34.67
Total Common Shares Outstanding	43.77	43.77	43.77	43.77	43.77	34.67
Working Capital	189.47	193.64	210.4	216.52	233.71	84.28
Book Value Per Share	8.98	8.89	9.83	10.07	10.66	9.94
Tangible Book Value	387.3	383.12	408.63	418.36	443.97	314.49
Tangible Book Value Per Share	8.85	8.75	9.34	9.56	10.14	9.07
Land	59.45	59.45	59.45	59.45	59.45	59.45
Buildings	161.41	157.27	155.36	155.36	155.36	155.36
Machinery	60.93	60.92	59.99	55.23	54.34	52.55
Leasehold Improvements	2.5	2.5	2.5	2.5	2.5	2.5

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.